PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson’s disease (PD) and may avoid complications associated with levodopa, […]

PHILADELPHIA — The investigational agent ecopipam reduces tic severity in children and adolescents with Tourette syndrome (TS) without exacerbating common psychiatric comorbidities, results of a new […]

When Russia occupied and annexed Crimea in 2014, Ukraine’s neurosurgeons saw a grim preview of the full-scale war that was yet to come. “We lost not […]

COPENHAGEN, Denmark — Growing evidence supports the use of highly effective disease-modifying therapies for children with multiple sclerosis (MS). However, only few of these medications are […]

Eliezer Masliah, MD, director of the neuroscience division at the National Institute on Aging (NIA), has been “relieved of his position” following an investigation by the […]

COPENHAGEN, Denmark — Women of childbearing age with multiple sclerosis (MS) receive fewer highly effective medications than men with similar levels of disability, even after accounting […]

COPENHAGEN — Relative to starting on an immunomodulator and then switching to a more potent anti-CD20 monoclonal antibody, the likelihood of long-term accumulation of disability in […]

COPENHAGEN, Denmark — A higher cumulative genetic burden for depression is associated with an increased risk for relapse and worsening disability in people with multiple sclerosis […]